EBS
Emergent BioSolutions Inc
Price:  
3.30 
USD
Volume:  
5,156,017.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EBS Relative Valuation

-8015.5%
Upside

As of 2024-02-28, the Relative Valuation of Emergent BioSolutions Inc (EBS) is (261.21) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.30 USD, the upside of Emergent BioSolutions Inc based on Relative Valuation is -8015.5%.

The range of the Relative Valuation is (254.77) - (285.06) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 13.1x - 16.6x 13.9x
Forward P/E multiples 13.5x - 15.1x 13.7x
Fair Price (254.77) - (285.06) (261.21)
Upside -7820.5% - -8738.2% -8015.5%
3.30 USD
Stock Price
(261.21) USD
Fair Price

EBS Relative Valuation - Historical P/E Data

Date P/E
2024-02-27 -0.17
2024-02-26 -0.15
2024-02-23 -0.14
2024-02-22 -0.15
2024-02-21 -0.14
2024-02-20 -0.08
2024-02-16 -0.08
2024-02-15 -0.09
2024-02-14 -0.09
2024-02-13 -0.08
2024-02-12 -0.10
2024-02-09 -0.08
2024-02-08 -0.09
2024-02-07 -0.08
2024-02-06 -0.08
2024-02-05 -0.08
2024-02-02 -0.09
2024-02-01 -0.09
2024-01-31 -0.09
2024-01-30 -0.09
2024-01-29 -0.10
2024-01-26 -0.10
2024-01-25 -0.10
2024-01-24 -0.10
2024-01-23 -0.10
2024-01-22 -0.10
2024-01-19 -0.10
2024-01-18 -0.10
2024-01-17 -0.10
2024-01-16 -0.11
2024-01-12 -0.11
2024-01-11 -0.11
2024-01-10 -0.11
2024-01-09 -0.11
2024-01-08 -0.11
2024-01-05 -0.12
2024-01-04 -0.12
2024-01-03 -0.12
2024-01-02 -0.14
2023-12-29 -0.13
2023-12-28 -0.13
2023-12-27 -0.13
2023-12-26 -0.13
2023-12-22 -0.13
2023-12-21 -0.12
2023-12-20 -0.12
2023-12-19 -0.13
2023-12-18 -0.12
2023-12-15 -0.13
2023-12-14 -0.13